SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Cascadian Therapeutics (CASC)

CASC RSS Feed
Add CASC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 12/7/2016 10:52:26 AM - Followers: 87 - Board type: Free - Posts Today: 0

company web-site - http://www.oncothyreon.com
recent event / CC - http://ir.oncothyreon.com/events.cfm -

Oncothyreon is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. We are currently developing multiple therapeutic candidates designed to target cancer in specific and effective ways. Our pipeline includes both synthetic vaccines and small molecules for a variety of cancer indications.  Oncothyreon is headquartered in Bellevue, Washington. The Company is traded on the NASDAQ National Market under the symbol ONTY and on the Toronto Stock Exchange under the symbol ONY.   We are The Cancer Vaccine People(TM).

Stimuvax

ONTY's drug Stimuvax, in partnership with Merck KGaa, is now in large Phase 3 Pivotal Trial program for NSCLC:

Phase III NSCLC (Lung) "START" Trial - http://www.clinicaltrials.gov/ct2/show/NCT00409188

Phase III NSCLC "INSPIRE" Trial (Asia) - http://www.clinicaltrials.gov/ct2/show/NCT01015443

Phase II NSCLC w/Avastin Trial - http://www.clinicaltrials.gov/ct2/show/NCT00828009

Phase I/II NSCLC Trial in Japan http://www.clinicaltrials.gov/ct2/show/NCT00960115

Phase IV Long-Term Safety Trial - http://www.clinicaltrials.gov/ct2/show/NCT01423760

Phase II HDPC Trial - http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-11-C-0247

 Pipe-Line - http://www.oncothyreon.com/pipeline/overview.html

Remaining Pipe-Line -

ONT-10 - http://www.oncothyreon.com/pipeline/vaccines/ONT-10/overview.html

PX-866 - http://www.oncothyreon.com/pipeline/small/PX-866/overview.html

          Start of Trial with Taxotere - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=526661

          Start of Trial with Erbitux - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=537953

PRESS RELEASES

Oncothyreon Initiates Phase 2 Trial of its PI-3 Kinase Inhibitor PX-866 in Patients with Glioblastoma - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=561867

Oncothyreon Presents Preclinical Data for ONT-10 and PX-866 at American Association for Cancer Research - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=561521

Oncothyreon Announces Publication of Safety & Survival Data From Stimuvax Phase 1/2 NSCLC Trial - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=515788

Oncothyreon Initiates Phase 1/2 Trial of its PI-3 Kinase Inhibitor PX-866 in Combination with Cetuximab - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=537953

Oncothyreon announces that Merck Serono is resuming the Stimuvax clinical program in lung cancer - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=480296

Oncothyreon announces temporary suspension of Stimuvax clinical trials - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=453976

Oncothyreon announces STRIDE Phase 3 BC trial - June 22, 2009 http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38926533

Oncothyreon announces clinical data at ASCO - May 30, 2009 - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38259984

Oncothyreon announces development plans - Dec. 18, 2008 - http://biom.client.shareholder.com/releasedetail.cfm?ReleaseID=355043

Merck KGaA buys manufacturing rights for Stimuvax - Dec. 18, 2008 - http://biom.client.shareholder.com/releasedetail.cfm?ReleaseID=355037

ONTY/Merck KGaA amend agreements - Aug 8, 2007http://www.marketwatch.com/news/story/biomira-merck-kgaa-sign-amended/story.aspx?guid=%7B43FD62A1%2D....

MEDICAL PRESENTATIONS

ASCO 2007 Stimuvax Abstract - http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=32165

"16 pts were evaluated for this interim safety analysis ..........As of September 2006, 10 pts were still on study treatment."

ASCO 2008 Stimuvax Abstract - http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=55&abstractID=34755

"The 2-year survival rate of 64% ....compares favorably with previously reported survival for chemoradiation in stage III NSCLC."

ASCO 2009 Stimuvax Abstract - http://www.abstract.asco.org/AbstView_65_31704.html

"a remarkable # of pts received prolonged treatment...16 pts received L-BLP25 for 2.0-7.7 years, 10 pts were treated for >5 years."

COMPLETE MEDICAL PAPERS

  Paper summarizing all Stimuvax trials to date - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39761211

  Publication of Data From Phase 1/2 NSCLC Trial - http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=515788 

  A Peptide Vaccine Strategy in NSCLC - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39627241

 Phase IIb Trial in NSCLC Stage IIIB and IV - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39099793

"The greatest difference in survival was observed in stage IIIB LR patients (adjusted HR = 0.524; 95% CI, 0.261 to 1.052; P = .069)"

 - Fig 3. Overall survival by study arm - http://jco.ascopubs.org/cgi/content-nw/full/23/27/6674/F3

 - Fig 4. Survival analysis for stage IIIB with MFE or stage IV patients - http://jco.ascopubs.org/cgi/content-nw/full/23/27/6674/F4

 - Fig 5. Survival analysis for stage IIIB locoregional patients - http://jco.ascopubs.org/cgi/content-nw/full/23/27/6674/F5


 Detailed Description of START Trial - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39062424

First Interim Look - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=58060227


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CASC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CASC News: Current Report Filing (8-k) 12/07/2016 07:26:51 AM
CASC News: Cascadian Therapeutics Amends HER2CLIMB Phase 2 Trial of Tucatinib in Metastatic HER2-Positive Breast Cancer to Support Regis... 12/07/2016 07:00:00 AM
CASC News: Cascadian Therapeutics Strengthens Management Team with Key Hires, Monique M. Greer and Marc C. Chamberlain, M.D. 11/28/2016 08:00:00 AM
CASC News: Current Report Filing (8-k) 11/23/2016 04:11:42 PM
CASC News: Cascadian Therapeutics Announces Stockholders and Board of Directors Approve Reverse Stock Split 11/23/2016 04:05:00 PM
PostSubject
#786   nice coin, snupoled 12/07/16 10:52:26 AM
#785   excuse me Snupdawg casc has news that you snupoled 12/07/16 08:29:14 AM
#784   nice swing back up yesterday a leak? no snupoled 12/07/16 08:16:50 AM
#783   symposium, we present after 5pm tomorrow wed snupoled 12/06/16 01:27:17 PM
#782   quite a see saw of pps snupoled 12/03/16 10:06:02 AM
#781   well a new day snupoled 12/02/16 09:59:34 AM
#780   Man, I am being brought to the wood snupoled 12/01/16 03:20:38 PM
#779   You thought that was bad 5.04 low for snupoled 12/01/16 02:51:15 PM
#778   93 cents pre rs or 5.60 a share ouch snupoled 11/29/16 03:30:16 PM
#777   5.83 holding steady near .97 cents pre split snupoled 11/29/16 01:57:09 PM
#776   last day to get out pre rs snupoled 11/28/16 08:11:47 AM
#775   rs on tues morning same symbol snupoled 11/25/16 12:23:35 PM
#774   Jnizz, picked up a few today, rs before dec.31 snupoled 11/23/16 10:01:16 AM
#773   They will be announcing between a 5-11 to Panzer 11/12/16 01:20:50 AM
#772   When is are a split? harmsen 11/08/16 05:36:24 AM
#771   All bios down casc especially hit I'm buying Panzer 11/03/16 06:10:06 PM
#770   What is happening here?!?!? WAM2 11/02/16 02:31:50 PM
#769   Doesn't make much sense... even with good results Jnizz 11/01/16 09:57:43 AM
#768   Reverse split Fist Full of Dollars 10/28/16 04:32:26 PM
#767   What is happening here. Great results so why WAM2 10/28/16 11:58:22 AM
#766   Buying CASC here Panzer 10/13/16 09:57:05 AM
#765   Can anyone tell me please if Monday's poster W&T Capital LLC 10/07/16 10:43:21 PM
#764   Agree great hold through EOY Panzer 10/05/16 03:39:18 PM
#763   CASC bullish 1.725 stocktrademan 10/04/16 11:56:41 AM
#762   Very nice. I bought 1000 shares when they realnewb 09/28/16 10:54:04 PM
#761   Reloading big with dip Panzer 09/28/16 10:49:11 PM
#760   Just trimmed 50% of position profits here Panzer 09/28/16 10:48:42 PM
#759   CASC formerly ONTY up over 20% 4x volume realnewb 09/27/16 08:54:12 AM
#758   Casc up big on huge EOD and after realnewb 09/26/16 11:15:17 PM
#757   Where is everybody!? There's a long run ahead! realnewb 09/26/16 11:14:19 PM
#756   CASC bullish 1.17 stocktrademan 07/21/16 01:13:50 PM
#755   This Investor Just Grabbed 25 Million Shares Of venturecapp 07/12/16 01:09:52 PM
#754   CASC looking good going into Monday. Great ah Green_Goblin 07/10/16 12:44:44 PM
#753   CASC: Cascadian Therapeutics Receives ONT-380 Fast Track Designation aries4747 06/29/16 10:47:12 AM
#752   CASC: Cascadian Therapeutics Has Gross Proceeds of $32.2M aries4747 06/29/16 10:45:47 AM
#751   Likely futile U.K. petition for 2nd Brexit referendum casinoo 06/25/16 05:35:28 PM
#750   they can do both or either or for casc parrishilton 06/23/16 05:27:46 PM
#749   yes finally came out casc parrishilton 06/23/16 05:26:52 PM
#748   casc needs some good news soon parrishilton 06/23/16 05:24:22 PM
#747   not sure if this is good or bad parrishilton 06/23/16 05:23:32 PM
#746   This is taking a beating today. dave86 06/14/16 12:38:51 PM
#745   thx no mods for this board it seems croptop 06/09/16 05:31:46 PM
#744   Board Moderators request the change: 4on4off 06/09/16 04:59:31 PM
#743   Do Mods change symbol or start a new board? croptop 06/09/16 12:56:51 PM
#742   (ONTY) Oncothyreon Inc. changes its name Manalo84 06/08/16 08:24:03 AM
#741   Positive Phase 1 results Manalo84 06/06/16 07:36:19 AM
#740   Shareholder meeting June 23 Manalo84 06/02/16 01:03:35 PM
#739   Quarterly is out. The separation agreement with JeffAdams05 05/09/16 11:17:38 PM
#738   Finally a nice move here today...patience pays! pennywizard61 04/25/16 07:45:55 PM
#737   no idea Killian, they are all a crap croptop 04/25/16 04:04:28 PM
PostSubject